Integrated analysis of copy number variation and genome-wide expression profiling in colorectal cancer tissues

PLoS ONE

Volumn 9, Issue 4, 2014, Pages

  Hassan, Nur Zarina Ali ^a   Mokhtar, Norfilza Mohd ^a,b   Sin, Teow Kok ^a   Rose, Isa Mohamed ^b   Sagap, Ismail ^b   Harun, Roslan ^a,b   Jamal, Rahman ^a  

^a UNIVERSITI KEBANGSAAN MALAYSIA   (Malaysia)

^b DEPARTMENT OF PHARMACOLOGY   (Malaysia)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTOME;

ADULT; ARTICLE; CHD6 GENE; CHROMOSOME 20; CHROMOSOME 20Q12; CHROMOSOME 22; CHROMOSOME 8; CHROMOSOME 8P23.2; COLON MUCOSA; COLORECTAL CANCER; CONTROLLED STUDY; COPY NUMBER VARIATION; CSMD1 GENE; DLC1 GENE; DOWN REGULATION; EMILIN3 GENE; GENE EXPRESSION PROFILING; GENE LOSS; GENE MAPPING; GENETIC DATABASE; GENETIC GAIN; GENOME ANALYSIS; HUMAN; HUMAN TISSUE; KEGG DATABASE; MAJOR CLINICAL STUDY; MALE; PRIMARY TUMOR; PTPRT GENE; UPREGULATION; VALIDATION STUDY;

EID: 84898829345     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0092553     Document Type: Article

References (57)

1. Cunningham D, Atkin W, Lenz HJ, Lynch HT, Minsky B, et al. (2010) Colorectal cancer. Lancet 375: 1030-1047.
2. Jemal A, Bray F, Center MM, Ferlay J, Ward E, et al. (2011) Global cancer statistics. CA: a cancer journal for clinicians 61: 69-90.
3. Zainal Ariffin O, Nor Saleha IT (2011) National Cancer Registry Report 2007. Kuala Lumpur: Ministry of Health.
4. Issa JP (2008) Colon cancer: it's CIN or CIMP. Clinical cancer research : an official journal of the American Association for Cancer Research 14: 5939-5940.
5. Gordon DJ, Resio B, Pellman D (2012) Causes and consequences of aneuploidy in cancer. Nature reviews Genetics 13: 189-203.
6. Redon R, Ishikawa S, Fitch KR, Feuk L, Perry GH, et al. (2006) Global variation in copy number in the human genome. Nature 444: 444-454. (Pubitemid 44809057)
7. Chaignat E, Yahya-Graison EA, Henrichsen CN, Chrast J, Schutz F, et al. (2011) Copy number variation modifies expression time courses. Genome research 21: 106-113.
8. Nakao M, Kawauchi S, Furuya T, Uchiyama T, Adachi J, et al. (2009) Identification of DNA copy number aberrations associated with metastases of colorectal cancer using array CGH profiles. Cancer genetics and cytogenetics 188: 70-76.
9. Lassmann S, Weis R, Makowiec F, Roth J, Danciu M, et al. (2007) Array CGH identifies distinct DNA copy number profiles of oncogenes and tumor suppressor genes in chromosomal- and microsatellite-unstable sporadic colorectal carcinomas. Journal of molecular medicine 85: 293-304.
10. Jones AM, Douglas EJ, Halford SE, Fiegler H, Gorman PA, et al. (2005) Array-CGH analysis of microsatellite-stable, near-diploid bowel cancers and comparison with other types of colorectal carcinoma. Oncogene 24: 118-129. (Pubitemid 40143871)
11. Alcock HE, Stephenson TJ, Royds JA, Hammond DW (2003) Analysis of colorectal tumor progression by microdissection and comparative genomic hybridization. Genes, chromosomes & cancer 37: 369-380. (Pubitemid 36775779)
12. Lipska L, Visokai V, Levy M, Svobodova S, Kormunda S, et al. (2007) Tumor markers in patients with relapse of colorectal carcinoma. Anticancer research 27: 1901-1905. (Pubitemid 46954695)
13. Wu X, Zhang D, Li G (2012) Insights into the regulation of human CNV-miRNAs from the view of their target genes. BMC genomics 13: 707.
14. Poptsova M, Banerjee S, Gokcumen O, Rubin MA, Demichelis F (2013) Impact of constitutional copy number variants on biological pathway evolution. BMC evolutionary biology 13: 19.
15. Woodwark C, Bateman A (2011) The characterisation of three types of genes that overlie copy number variable regions. PloS one 6: e14814.
16. Stranger BE, Forrest MS, Dunning M, Ingle CE, Beazley C, et al. (2007) Relative impact of nucleotide and copy number variation on gene expression phenotypes. Science 315: 848-853.
17. Camps J, Nguyen QT, Padilla-Nash HM, Knutsen T, McNeil NE, et al. (2009) Integrative genomics reveals mechanisms of copy number alterations responsible for transcriptional deregulation in colorectal cancer. Genes, chromosomes & cancer 48: 1002-1017.
18. Bergamaschi A, Kim YH, Wang P, Sorlie T, Hernandez-Boussard T, et al. (2006) Distinct patterns of DNA copy number alteration are associated with different clinicopathological features and gene-expression subtypes of breast cancer. Genes, chromosomes & cancer 45: 1033-1040. (Pubitemid 44435537)
19. Lu TP, Lai LC, Tsai MH, Chen PC, Hsu CP, et al. (2011) Integrated analyses of copy number variations and gene expression in lung adenocarcinoma. PloS one 6: e24829.
20. (2012) Comprehensive molecular characterization of human colon and rectal cancer. Nature 487: 330-337.
21. Jasmine F, Rahaman R, Dodsworth C, Roy S, Paul R, et al. (2012) A genome-wide study of cytogenetic changes in colorectal cancer using SNP microarrays: opportunities for future personalized treatment. PloS one 7: e31968.
22. Xie T, G DA, Lamb JR, Martin E, Wang K, et al. (2012) A comprehensive characterization of genome-wide copy number aberrations in colorectal cancer reveals novel oncogenes and patterns of alterations. PloS one 7: e42001.
23. Carvalho B, Postma C, Mongera S, Hopmans E, Diskin S, et al. (2009) Multiple putative oncogenes at the chromosome 20q amplicon contribute to colorectal adenoma to carcinoma progression. Gut 58: 79-89.
24. Tsafrir D, Bacolod M, Selvanayagam Z, Tsafrir I, Shia J, et al. (2006) Relationship of gene expression and chromosomal abnormalities in colorectal cancer. Cancer research 66: 2129-2137.
25. Kimura Y, Noguchi T, Kawahara K, Kashima K, Daa T, et al. (2004) Genetic alterations in 102 primary gastric cancers by comparative genomic hybridization: gain of 20q and loss of 18q are associated with tumor progression. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 17: 1328-1337. (Pubitemid 39472987)
26. Wang JC (2002) Cellular roles of DNA topoisomerases: a molecular perspective. Nature reviews Molecular cell biology 3: 430-440.
27. Romer MU, Nygard SB, Christensen IJ, Nielsen SL, Nielsen KV, et al. (2013) Topoisomerase 1(TOP1) gene copy number in stage III colorectal cancer patients and its relation to prognosis. Molecular oncology 7: 101-111.
28. Smith DH, Christensen IJ, Jensen NF, Markussen B, Romer MU, et al. (2013) Mechanisms of Topoisomerase I (TOP1) Gene Copy Number Increase in a Stage III Colorectal Cancer Patient Cohort. PloS one 8: e60613.
29. Thomas SM, Coppelli FM, Wells A, Gooding WE, Song J, et al. (2003) Epidermal growth factor receptor-stimulated activation of phospholipase Cgamma-1 promotes invasion of head and neck squamous cell carcinoma. Cancer research 63: 5629-5635. (Pubitemid 37139888)
30. Jones NP, Peak J, Brader S, Eccles SA, Katan M (2005) PLCgamma1 is essential for early events in integrin signalling required for cell motility. Journal of cell science 118: 2695-2706. (Pubitemid 40932894)
31. Wells A, Grandis JR (2003) Phospholipase C-gamma1 in tumor progression. Clinical & experimental metastasis 20: 285-290.
32. Blume-Jensen P, Hunter T (2001) Oncogenic kinase signalling. Nature 411: 355-365. (Pubitemid 32467045)
33. Tan DS, Iravani M, McCluggage WG, Lambros MB, Milanezi F, et al. (2011) Genomic analysis reveals the molecular heterogeneity of ovarian clear cell carcinomas. Clinical cancer research : an official journal of the American Association for Cancer Research 17: 1521-1534.
34. Sheffer M, Bacolod MD, Zuk O, Giardina SF, Pincas H, et al. (2009) Association of survival and disease progression with chromosomal instability: a genomic exploration of colorectal cancer. Proceedings of the National Academy of Sciences of the United States of America 106: 7131-7136.
35. Ma C, Quesnelle KM, Sparano A, Rao S, Park MS, et al. (2009) Characterization CSMD1 in a large set of primary lung, head and neck, breast and skin cancer tissues. Cancer biology & therapy 8: 907-916.
36. Deng N, Goh LK, Wang H, Das K, Tao J, et al. (2012) A comprehensive survey of genomic alterations in gastric cancer reveals systematic patterns of molecular exclusivity and co-occurrence among distinct therapeutic targets. Gut 61: 673-684.
37. Kamal M, Shaaban AM, Zhang L, Walker C, Gray S, et al. (2010) Loss of CSMD1 expression is associated with high tumour grade and poor survival in invasive ductal breast carcinoma. Breast cancer research and treatment 121: 555-563.
38. Jia D, Wei L, Guo W, Zha R, Bao M, et al. (2011) Genome-wide copy number analyses identified novel cancer genes in hepatocellular carcinoma. Hepatology 54: 1227-1236.
39. Hawthorn L, Luce J, Stein L, Rothschild J (2010) Integration of transcript expression, copy number and LOH analysis of infiltrating ductal carcinoma of the breast. BMC cancer 10: 460.
40. Lagerstedt KK, Staaf J, Jonsson G, Hansson E, Lonnroth C, et al. (2007) Tumor genome wide DNA alterations assessed by array CGH in patients with poor and excellent survival following operation for colorectal cancer. Cancer informatics 3: 341-355.
41. Huang V, Place RF, Portnoy V, Wang J, Qi Z, et al. (2012) Upregulation of Cyclin B1 by miRNA and its implications in cancer. Nucleic acids research 40: 1695-1707.
42. Rodel F, Keppner S, Capalbo G, Bashary R, Kaufmann M, et al. (2010) Pololike kinase 1 as predictive marker and therapeutic target for radiotherapy in rectal cancer. The American journal of pathology 177: 918-929.
43. Senapati S, Ho SB, Sharma P, Das S, Chakraborty S, et al. (2010) Expression of intestinal MUC17 membrane-bound mucin in inflammatory and neoplastic diseases of the colon. Journal of clinical pathology 63: 702-707.
44. Tang X, Wu H, Wu Z, Wang G, Wang Z, et al. (2008) Carboxylesterase 2 is downregulated in colorectal cancer following progression of the disease. Cancer investigation 26: 178-181. (Pubitemid 351225462)
45. Walworth NC (2000) Cell-cycle checkpoint kinases: checking in on the cell cycle. Current opinion in cell biology 12: 697-704.
46. Malumbres M, Barbacid M (2009) Cell cycle, CDKs and cancer: a changing paradigm. Nature reviews Cancer 9: 153-166.
47. Kristjansdottir K, Rudolph J (2004) Cdc25 phosphatases and cancer. Chemistry & biology 11: 1043-1051. (Pubitemid 39138756)
48. Goldstone S, Pavey S, Forrest A, Sinnamon J, Gabrielli B (2001) Cdc25-dependent activation of cyclin A/cdk2 is blocked in G2 phase arrested cells independently of ATM/ATR. Oncogene 20: 921-932. (Pubitemid 32207109)
49. Loffler H, Rebacz B, Ho AD, Lukas J, Bartek J, et al. (2006) Chk1-dependent regulation of Cdc25B functions to coordinate mitotic events. Cell cycle 5: 2543-2547. (Pubitemid 44785834)
50. Takemasa I, Yamamoto H, Sekimoto M, Ohue M, Noura S, et al. (2000) Overexpression of CDC25B phosphatase as a novel marker of poor prognosis of human colorectal carcinoma. Cancer research 60: 3043-3050. (Pubitemid 30395833)
51. Lindqvist A, Kallstrom H, Karlsson Rosenthal C (2004) Characterisation of Cdc25B localisation and nuclear export during the cell cycle and in response to stress. Journal of cell science 117: 4979-4990. (Pubitemid 39517514)
52. Aressy B, Bugler B, Valette A, Biard D, Ducommun B (2008) Moderate variations in CDC25B protein levels modulate the response to DNA damaging agents. Cell cycle 7: 2234-2240. (Pubitemid 352031526)
53. Bugler B, Quaranta M, Aressy B, Brezak MC, Prevost G, et al. (2006) Genotoxic-activated G2-M checkpoint exit is dependent on CDC25B phosphatase expression. Molecular cancer therapeutics 5: 1446-1451. (Pubitemid 44070480)
54. Strzalka W, Ziemienowicz A (2011) Proliferating cell nuclear antigen (PCNA): a key factor in DNA replication and cell cycle regulation. Annals of botany 107: 1127-1140.
55. Henley SA, Dick FA (2012) The retinoblastoma family of proteins and their regulatory functions in the mammalian cell division cycle. Cell division 7: 10.
56. Platzer P, Upender MB, Wilson K, Willis J, Lutterbaugh J, et al. (2002) Silence of chromosomal amplifications in colon cancer. Cancer research 62: 1134-1138. (Pubitemid 34160299)
57. Kotliarov Y, Kotliarova S, Charong N, Li A, Walling J, et al. (2009) Correlation analysis between single-nucleotide polymorphism and expression arrays in gliomas identifies potentially relevant target genes. Cancer research 69: 1596-1603.